RxParadigm Partners with NACHC Select to Advance Next-Generation 340B and Medicare MFP Execution
PHILADELPHIA, PA, UNITED STATES, April 2, 2026 /EINPresswire.com/ -- RxParadigm, a leading enterprise-grade platform for end-to-end 340B drug administration, Medicare Maximum Fair Price (MFP) effectuation, and rebate administration, today announced a strategic partnership with the National Association of Community Health Centers (NACHC) Select Group Purchasing Organization (GPO) program to support next-generation GPO and compliance execution for Community Health Centers (CHCs) nationwide.
Through this partnership, NACHC Select and RxParadigm aim to reduce financial and administrative burden for CHCs while delivering a next-generation solution designed to maintain compliance amid evolving 340B program requirements. RxParadigm’s Tungsten+PLUS™ platform provides a centralized, validated data infrastructure aligned with CMS expectations and engineered to support current and future federal mandates, including 340B rebate models, Medicare MFP implementation, evolving regulatory frameworks, and forward-inventory purchasing models.
RxParadigm’s Tungsten+PLUS™ platform delivers a neutral, enterprise-grade infrastructure that enables execution of complex pricing and compliance requirements at scale. Core capabilities include Medicare MFP effectuation and reconciliation, 340B rebate administration, duplicate-discount prevention, and a centralized clearinghouse serving as a secure, validated data repository for NACHC member health centers.
The platform also provides advanced 340B data validation to certify eligible versus non-eligible claims; secure, interoperable data transmission supporting manufacturers, wholesalers, third-party administrators, and payers; and comprehensive administrative and operational support for GPO, formulary, rebate, and reporting workflows. This integrated approach enables greater transparency, auditability, and operational efficiency across the drug supply chain.
“We are excited to partner with NACHC and its member health centers to deliver next-generation GPO services,” said Mesfin Tegenu, Chief Executive Officer of RxParadigm. “Tungsten+PLUS™ was purpose-built for this moment in the 340B program—where innovation, neutrality, and execution-ready infrastructure are essential. Our platform, combined with forward-deployed inventory integrations and neutral clearinghouse services, enables stakeholders to meet today’s requirements while preparing for the future of Medicare MFP and federal drug-pricing reform.”
About RxParadigm
RxParadigm is a healthcare technology company delivering neutral, enterprise-grade platforms for 340B administration, Medicare MFP effectuation, rebate management, and drug-pricing compliance. Its Tungsten+PLUS™ clearinghouse enables validated data exchange, reconciliation, and audit-ready execution across manufacturers, health systems, pharmacies, and federal programs.
About NACHC
NACHC’s mission is to champion Community Health Centers delivering affordable, effective, comprehensive primary care that is community-driven and improves health for all. For more information, visit www.nachc.org.
Established in 2023, NACHC Select is a wholly owned subsidiary of NACHC that seeks to develop relationships with industry leaders to provide savings and other special offers for the high-quality products and services community health centers need.
Carlo Cioffi
RxParadigm
+1 3025244179
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
